CardiologyRounds.com

A Professional & Personal Networking Site for Cardiologists Worldwide

Dr.Murali Krishna

First Heart Transplants in Children Following Donor Cardiac Death

US doctors have reported the first experiences of heart transplant in three infants after cardiocirculatory death, rather than brain death, in the donors [1]. Lead author Dr Mark M Boucek (Joe DiMaggio Children's Hospital, Hollywood, FL) told heartwire this was, to his knowledge, the first published account of heart transplant in children after donor cardiac death, although organs other than hearts are transplanted after cardiac death.

More at http://www.medscape.com/viewarticle/579079

▶ Reply to This

CardiologyRounds


Cardiology Rounds


Birthdays

Birthdays Tomorrow

Badge

Loading…

Get Badge

NEJM Cardiology

ORIGINAL ARTICLE: Adverse Events Associated with Testosterone Administration

CORRESPONDENCE: 24-Hour Ambulatory Blood Pressure in the ACCOMPLISH Trial

EDITORIAL: Carotid-Artery Stenting in Stroke Prevention

ORIGINAL ARTICLE: Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis

ORIGINAL ARTICLE: Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction

PERSPECTIVE: Coronary Heart Disease and Prevention in the United States

CORRESPONDENCE: Food Reformulations to Reduce Trans Fatty Acids

EDITORIAL: Hypoplastic Left Heart Syndrome

ORIGINAL ARTICLE: Comparison of Shunt Types in the Norwood Procedure for Single-Ventricle Lesions

EDITORIAL: Fear of Rejection — Monitoring the Heart-Transplant Recipient

The Heart

Transradial PCI approach reduces bleeding, MACE in STEMI patients

COR-I: Combo drug leads to significant weight loss, but CV effects questioned

Sanofi-Aventis sues FDA over generic Lovenox approval

Advisory panel votes to recommend FDA approval of ticagrelor

Two new randomized trials bolster benefits of compression-only CPR

Traditional tools for gauging neurological prognosis post-cardiac arrest may no longer be accurate: Study

Taking patients directly to existing PCI centers is more cost-effective than expanding PCI capacity

Dr Terry Ferguson moves on to AstraZeneca

Arguments continue over the metabolic syndrome

Avoiding lowest-volume centers and adhering to quality measures lower cost of CABG overall

JACC

Inside This Issue

Clinical Characteristics of Patients Undergoing Surgical Ventricular Reconstruction by Choice and by Randomization

Evaluating Clinical Applicability: The STICH Trial's Findings

Snakelike Aortic Right Ventricular Tunnel With Anomalous Origin of Left Main Coronary Artery in an Adult Woman

The 9p21 Locus and Coronary Heart Disease: Initiator, Promoter, or Precipitator?

Eptifibatide Is Noninferior to Abciximab in Primary Percutaneous Coronary Intervention: Results From the SCAAR (Swedish Coronary Angiography and Angioplasty Registry)

Gene Dosage of the Common Variant 9p21 Predicts Severity of Coronary Artery Disease

The Glycoprotein IIb/IIIa Inhibitor Wars: An Update

STICH (Surgical Treatment for Ischemic Heart Failure) Trial Enrollment

Minimally-Invasive Implantation of Living Tissue Engineered Heart Valves: A Comprehensive Approach From Autologous Vascular Cells to Stem Cells

© 2010   Cardiology Rounds

Contact US  |  Report an Issue  |  Terms of Service

Sign in to chat!